RAS2410 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a selective inhibitor targeting specific pathways involved in cell proliferation and survival. This makes it a valuable tool in understanding the mechanisms of tumor growth and in the development of targeted treatments for various types of cancers. Additionally, RAS2410 is employed in preclinical studies to evaluate its efficacy and safety profile, aiding in the identification of potential therapeutic windows and optimal dosing strategies. Its role in inhibiting key signaling molecules also extends to research in autoimmune diseases, where it helps in exploring new avenues for modulating immune responses.